The introduction of green fluorescent protein and its variants (GFPs) has allowed protein analysis at the level of the cell. Now, chemical methods are needed to label proteins in vivo with a wider variety of functionalities so that mechanistic questions about protein function in the complex cellular environment can be addressed. Here we demonstrate that trimethoprim derivatives can be used to selectively tag Escherichia coli dihydrofolate reductase (eDHFR) fusion proteins in wild-type mammalian cells with minimal background and fast kinetics.

SummaryMaintaining a physical connection across cytoplasm is crucial for many biological processes such as matrix force generation, cell motility, cell shape and tissue development. However, in the absence of stress fibers, the coherent structure that transmits force across the cytoplasm is not understood. We find that nonmuscle myosin-II (NMII) contraction of cytoplasmic actin filaments establishes a coherent cytoskeletal network irrespective of the nature of adhesive contacts. When NMII activity is inhibited during cell spreading by Rho kinase inhibition, blebbistatin, caldesmon overexpression or NMIIA RNAi, the symmetric traction forces are lost and cell spreading persists, causing cytoplasm fragmentation by membrane tension that results in 'C' or dendritic shapes. Moreover, local inactivation of NMII by chromophore-assisted laser inactivation causes local loss of coherence. Actin filament polymerization is also required for cytoplasmic coherence, but microtubules and intermediate filaments are dispensable. Loss of cytoplasmic coherence is accompanied by loss of circumferential actin bundles. We suggest that NMIIA creates a coherent actin network through the formation of circumferential actin bundles that mechanically link elements of the peripheral actin cytoskeleton where much of the force is generated during spreading. Adelstein, 2008;Vicente-Manzanares et al., 2009;Wylie and Chantler, 2008). NMIIA and NMIIB are the primary force generators in fibroblasts (Cai et al., 2006;Lo et al., 2004). Phosphorylation of myosin light chains (MLC), primarily by Rho kinases (ROCK) and MLC kinase (Totsukawa et al., 2004), regulates the NMII activity. ROCK has multiple protein targets including MLC, MLC phosphatase, adducin and moesin (Totsukawa et al., 2004). ROCK activates NMII by phosphorylating MLC and also by inactivating MLC phosphatase to inhibit MLC dephosphorylation (Totsukawa et al., 2004). Specific inhibitors have been developed for studying the functions of NMII, i.e. Y27632 inhibits ROCK and blebbistatin inhibits the ATPase activity of myosin-II. In addition to MLC phosphatase, some other proteins also negatively regulate NMII activity. For example, caldesmon interacts with actin, myosin-II and tropomyosin, and inhibits the ATPase activity of myosin-II (Marston et al., 1998). Caldesmon overexpression causes suppression of traction forces and focal adhesions (Helfman et al., 1999). Thus, there are a variety of ways to inhibit force generation on substrates.The plasma membrane limits the spreading of cells on substrates, and tension in the plasma membrane inhibits the ability of actin to polymerize at the periphery (Raucher and Sheetz, 2000). Although the tension in the membrane is typically very low (Sheetz, 2001), it can influence the behavior of cells (Keren et al., 2008) and the final shape of cells is heavily influenced by the final membrane area.We here demonstrate that NMIIA is crucial for the mechanical coherence of cytoplasm. Inhibition of NMII contractility or depletion of NMIIA causes cytoplasm to ...

Iron increases the synthesis of the ironstorage protein, ferritin, largely by promoting translation of preexisting mRNAs for both the H and L ferritin isoforms (H,

No abstract

Epithelial barrier loss is a driver of intestinal and systemic diseases. Myosin light chain kinase (MLCK) is a key effector of barrier dysfunction and a potential therapeutic target, but enzymatic inhibition has unacceptable toxicities. Here, we show that a unique domain within the MLCK splice-variant MLCK1 directs perijunctional actomyosin ring (PAMR) recruitment. Using the domain structure and multiple screens, we identified a domain-binding small molecule (Divertin) that blocks MLCK1 recruitment without inhibiting enzymatic function. Divertin blocks acute, TNF-induced MLCK1 recruitment as well as downstream MLC phosphorylation, barrier loss, and diarrhea in vitro and in vivo . Divertin corrects barrier dysfunction and prevents disease development and progression in experimental inflammatory bowel disease. Beyond applications of Divertin in gastrointestinal disease, this general approach to enzymatic inhibition by preventing access to specific subcellular sites provides a new paradigm for safely and precisely targeting individual properties of enzymes with multiple functions.